GZ-793A
GZ-793A is an orally active and selective vesicular monoamine transporter-2 (VMAT2) inhibitor, with an Ki of 0.029 μM. GZ-793A inhibits the neurochemical effects of methamphetamine (METH) -induced dopamine release. GZ-793A can be used for research of METH addiction[1][2][3].
Product Specifications
CAS Number
[1356447-90-9]
UNSPSC
12352005
Hazard Statement
H410
Target
Monoamine Transporter
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gz-793a.html
Purity
99.50
Solubility
H2O : 3 mg/mL (ultrasonic; warming)
Smiles
OC[C@H](O)CN1[C@H](CCC[C@H]1CCC2=CC=C(C=C2)OC)CCC3=CC=C(C=C3)OC.Cl
Molecular Formula
C26H38ClNO4
Molecular Weight
464.04
Precautions
H410
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items